GAUNFACINE

GAUNFACINE was reported 3772 times

GAUNFACINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GLYCOGEN STORAGE DISEASE TYPE VIII 3 0.2143
1 MACULAR DETACHMENT 18 0.0744
2 DISRUPTIVE MOOD DYSREGULATION DISORDER 4 0.0541
3 ANTICHOLINERGIC EFFECT 4 0.0533
4 NAIL PICKING 2 0.0444
5 SWEAT TEST ABNORMAL 3 0.0441
6 ELECTROCARDIOGRAM T WAVE AMPLITUDE INCREASED 4 0.0426
7 DEFIANT BEHAVIOUR 11 0.0357
8 RESTLESS LEG AUGMENTATION SYNDROME 5 0.0323
9 IMPERCEPTION 2 0.0282
10 CHOROIDAL EFFUSION 22 0.0274
11 KLEPTOMANIA 2 0.0274
12 INTENTIONAL MISUSE OF DRUG DELIVERY SYSTEM 2 0.0238
13 OPPOSITIONAL DEFIANT DISORDER 9 0.0228
14 GENDER DYSPHORIA 2 0.0227
15 HYPERTENSIVE URGENCY 11 0.0199
16 ATRIOVENTRICULAR DISSOCIATION 4 0.0187
17 SELF-DESTRUCTIVE BEHAVIOUR 16 0.0183
18 DRUG HALF-LIFE INCREASED 2 0.0175
19 BLOOD PROLACTIN DECREASED 3 0.0171
20 INTERMITTENT EXPLOSIVE DISORDER 2 0.0171
21 NEPHROGENIC DIABETES INSIPIDUS 19 0.0165
22 GRANDIOSITY 6 0.0164
23 CATHETER SITE DISCOLOURATION 2 0.0164
24 INTENTIONAL PRODUCT MISUSE TO CHILD 2 0.0155
25 CHORIORETINAL DISORDER 3 0.0152
26 BRIEF RESOLVED UNEXPLAINED EVENT 2 0.0152
27 ACTIVATION SYNDROME 5 0.0145
28 VENTRICULAR DYSKINESIA 3 0.0144
29 DRUG-GENETIC INTERACTION 5 0.0140
30 CYSTIC FIBROSIS RELATED DIABETES 2 0.0137
31 SEROUS RETINAL DETACHMENT 10 0.0119
32 ELECTROCARDIOGRAM ST-T SEGMENT ABNORMAL 5 0.0112
33 OROMANDIBULAR DYSTONIA 8 0.0110
34 PERIODIC LIMB MOVEMENT DISORDER 4 0.0109
35 CHOROIDAL DETACHMENT 6 0.0108
36 DISTRACTIBILITY 12 0.0104
37 DERMATILLOMANIA 6 0.0101
38 ADULTERATED PRODUCT 2 0.0100
39 ELECTROCARDIOGRAM T WAVE PEAKED 4 0.0100
40 ELECTROCARDIOGRAM QT SHORTENED 3 0.0099
41 CONDUCT DISORDER 2 0.0097
42 ANION GAP 6 0.0095
43 UPPER AIRWAY OBSTRUCTION 8 0.0090
44 SINUS ARREST 14 0.0089
45 IMPULSIVE BEHAVIOUR 33 0.0088
46 BRUGADA SYNDROME 9 0.0087
47 BODY MASS INDEX DECREASED 4 0.0086
48 TRICHOTILLOMANIA 5 0.0085
49 BRADYPNOEA 23 0.0085
50 SUBRETINAL FLUID 9 0.0082
51 DISTRIBUTIVE SHOCK 18 0.0079
52 ADHESIVE TAPE USE 3 0.0078
53 EDUCATIONAL PROBLEM 13 0.0078
54 POLYCYSTIC OVARIAN SYNDROME 3 0.0078
55 MALIGNANT CATATONIA 2 0.0076
56 ANION GAP ABNORMAL 2 0.0075
57 TIC 39 0.0071
58 ANTICHOLINERGIC SYNDROME 11 0.0069
59 GRIMACING 5 0.0064
60 PATIENT UNCOOPERATIVE 3 0.0063
61 ATTENTION DEFICIT HYPERACTIVITY DISORDER 26 0.0062
62 VASOPLEGIA SYNDROME 10 0.0061
63 SOCIAL ANXIETY DISORDER 4 0.0061
64 CATHETER SITE BRUISE 2 0.0060
65 BEHAVIOUR DISORDER 32 0.0059
66 NEGATIVISM 4 0.0053
67 ELECTROCARDIOGRAM T WAVE ABNORMAL 8 0.0051
68 SEDATION COMPLICATION 13 0.0051
69 HYPERTENSIVE EMERGENCY 6 0.0051
70 SINUS BRADYCARDIA 49 0.0051
71 CARDIAC ANEURYSM 5 0.0050
72 MANUFACTURING MATERIALS ISSUE 2 0.0050
73 HYPOPROTEINAEMIA 9 0.0047
74 CHANGE IN SEIZURE PRESENTATION 3 0.0046
75 ELEVATED MOOD 2 0.0046
76 INSULIN RESISTANCE 9 0.0043
77 MANUFACTURING ISSUE 2 0.0043
78 PROPOFOL INFUSION SYNDROME 3 0.0043
79 SYMPTOM MASKED 3 0.0041
80 CLONIC CONVULSION 3 0.0041
81 PRIAPISM 14 0.0041
82 PSYCHOMOTOR HYPERACTIVITY 65 0.0039
83 AGGRESSION 193 0.0039
84 INHIBITORY DRUG INTERACTION 6 0.0038
85 INSULIN-LIKE GROWTH FACTOR DECREASED 2 0.0038
86 HYPERMETABOLISM 2 0.0038
87 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 5 0.0037
88 CATATONIA 19 0.0036
89 INTENTION TREMOR 2 0.0035
90 HEAD BANGING 2 0.0035
91 HYPORESPONSIVE TO STIMULI 4 0.0034
92 EXCESSIVE EYE BLINKING 5 0.0034
93 ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC 3 0.0034
94 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 3 0.0034
95 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 17 0.0033
96 EOSINOPHILIC OESOPHAGITIS 9 0.0032
97 MEDICAL DEVICE SITE INFECTION 2 0.0032
98 IMMUNE THROMBOCYTOPENIC PURPURA 9 0.0032
99 PYELOCALIECTASIS 3 0.0031
100 NEPHROGENIC ANAEMIA 14 0.0030
101 SEROTONIN SYNDROME 58 0.0030
102 DISTURBANCE IN SOCIAL BEHAVIOUR 7 0.0030
103 CYST RUPTURE 2 0.0029
104 MAST CELL ACTIVATION SYNDROME 4 0.0028
105 STRESS CARDIOMYOPATHY 16 0.0027
106 ENURESIS 11 0.0027
107 DARK CIRCLES UNDER EYES 4 0.0027
108 AMINO ACID LEVEL INCREASED 2 0.0027
109 AFFECTIVE DISORDER 21 0.0027
110 SELF-INJURIOUS IDEATION 11 0.0026
111 DISINHIBITION 4 0.0025
112 IMPULSE-CONTROL DISORDER 5 0.0024
113 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 8 0.0024
114 TROPONIN I INCREASED 4 0.0024
115 AUTONOMIC NERVOUS SYSTEM IMBALANCE 7 0.0024
116 PHYSICAL ASSAULT 5 0.0024
117 PULSELESS ELECTRICAL ACTIVITY 10 0.0024
118 SLEEP DEFICIT 5 0.0024
119 INTENTIONAL OVERDOSE 151 0.0024
120 SUSPECTED SUICIDE 11 0.0023
121 CRANIOFACIAL FRACTURE 2 0.0023
122 ABNORMAL BEHAVIOUR 92 0.0023
123 BRADYCARDIA 121 0.0023
124 LOGORRHOEA 8 0.0023
125 HIRSUTISM 3 0.0023
126 INTENTIONAL SELF-INJURY 44 0.0022
127 BEZOAR 3 0.0022
128 CEREBRAL DISORDER 16 0.0022
129 ANGER 73 0.0022
130 CATHETER SITE SWELLING 2 0.0021
131 DYSTONIA 41 0.0021
132 STARING 5 0.0021
133 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 14 0.0021
134 DYSPHEMIA 9 0.0021
135 DRUG ADMINISTERED IN WRONG DEVICE 2 0.0020
136 PRODUCT ADMINISTRATION INTERRUPTED 16 0.0020
137 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 11 0.0020
138 TACHYPHRENIA 7 0.0020
139 PITUITARY TUMOUR 3 0.0020
140 OBSESSIVE-COMPULSIVE DISORDER 16 0.0020
141 SEDATION 52 0.0020
142 DRUG TOLERANCE 10 0.0020
143 HOMICIDAL IDEATION 8 0.0020
144 HOSTILITY 5 0.0020
145 CONSCIOUSNESS FLUCTUATING 2 0.0019
146 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 2 0.0019
147 NEUROMYOPATHY 2 0.0019
148 NEUROLEPTIC MALIGNANT SYNDROME 22 0.0019
149 ELECTROCARDIOGRAM QT PROLONGED 66 0.0018
150 OCULAR TOXICITY 2 0.0018
151 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 11 0.0018
152 RESPIRATORY DEPRESSION 22 0.0018
153 CONTRAINDICATED PRODUCT PRESCRIBED 3 0.0018
154 PRODUCT SUBSTITUTION ISSUE 102 0.0018
155 SLEEP TALKING 3 0.0018
156 DRUG EFFECT VARIABLE 2 0.0018
157 AFFECT LABILITY 17 0.0018
158 MOANING 2 0.0018
159 DRUG LEVEL ABOVE THERAPEUTIC 8 0.0017
160 HYPERTONIC BLADDER 5 0.0017
161 SCREAMING 11 0.0017
162 IRRITABILITY 102 0.0017
163 MEDICATION RESIDUE PRESENT 8 0.0017
164 REBOUND ACID HYPERSECRETION 5 0.0017
165 MANIA 27 0.0016
166 THERAPY CHANGE 16 0.0016
167 HYPERTRICHOSIS 3 0.0016
168 ATRIOVENTRICULAR BLOCK FIRST DEGREE 7 0.0016
169 CARDIAC DYSFUNCTION 6 0.0016
170 AGITATION 118 0.0016
171 RECALLED PRODUCT ADMINISTERED 15 0.0016
172 ADJUSTMENT DISORDER 2 0.0015
173 DEVICE MECHANICAL ISSUE 21 0.0015
174 DRUG DELIVERY SYSTEM ISSUE 3 0.0015
175 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 5 0.0015
176 HYPERPHAGIA 6 0.0015
177 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 4 0.0015
178 CARDIAC FAILURE ACUTE 10 0.0015
179 AREFLEXIA 4 0.0015
180 AGORAPHOBIA 2 0.0015
181 MICROCYTIC ANAEMIA 3 0.0014
182 PRE-EXISTING CONDITION IMPROVED 9 0.0014
183 CHRONIC FATIGUE SYNDROME 2 0.0014
184 ORTHOSTATIC HYPOTENSION 25 0.0014
185 DEVICE MATERIAL ISSUE 3 0.0014
186 SLEEP TERROR 6 0.0014
187 THERAPEUTIC RESPONSE CHANGED 9 0.0014
188 PRODUCT PREPARATION ISSUE 9 0.0014
189 NODAL RHYTHM 2 0.0014
190 CRANIOCEREBRAL INJURY 4 0.0013
191 BUNDLE BRANCH BLOCK RIGHT 6 0.0013
192 DROOLING 9 0.0013
193 REACTION TO EXCIPIENT 3 0.0013
194 BRUXISM 7 0.0013
195 DAYDREAMING 2 0.0013
196 THERAPEUTIC PRODUCT INEFFECTIVE 5 0.0013
197 RHINOVIRUS INFECTION 5 0.0013
198 MEGACOLON 2 0.0013
199 RESPIRATORY ACIDOSIS 5 0.0013
200 AUTISM SPECTRUM DISORDER 7 0.0013
201 URINARY TRACT OBSTRUCTION 3 0.0013
202 SINUS OPERATION 3 0.0013
203 WRONG DOSE 3 0.0012
204 FRUSTRATION TOLERANCE DECREASED 10 0.0012
205 EMOTIONAL DISORDER 38 0.0012
206 METABOLIC SYNDROME 2 0.0012
207 GENERALISED TONIC-CLONIC SEIZURE 20 0.0012
208 EXPIRED DEVICE USED 4 0.0012
209 SUICIDAL BEHAVIOUR 5 0.0012
210 HYPERAMMONAEMIA 6 0.0012
211 HYPERPARATHYROIDISM SECONDARY 3 0.0012
212 HALLUCINATION, AUDITORY 19 0.0012
213 EXPOSURE VIA INGESTION 3 0.0012
214 SUPRAVENTRICULAR EXTRASYSTOLES 4 0.0012
215 EXPOSURE TO SARS-COV-2 2 0.0012
216 DISSOCIATION 9 0.0012
217 LEFT VENTRICULAR HYPERTROPHY 5 0.0012
218 CHOREA 2 0.0012
219 INCORRECT STORAGE OF DRUG 2 0.0012
220 REBOUND EFFECT 13 0.0011
221 OTORRHOEA 2 0.0011
222 SINUS TACHYCARDIA 16 0.0011
223 DRUG WITHDRAWAL CONVULSIONS 2 0.0011
224 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 8 0.0011
225 HYPOMANIA 4 0.0011
226 BLOOD THYROID STIMULATING HORMONE ABNORMAL 2 0.0011
227 DISORGANISED SPEECH 2 0.0011
228 DRUG SCREEN FALSE POSITIVE 3 0.0011
229 CYSTIC FIBROSIS 6 0.0011
230 TREATMENT FAILURE 89 0.0011
231 ELECTRIC SHOCK SENSATION 3 0.0011
232 BLADDER SPASM 2 0.0011
233 DRUG TOLERANCE DECREASED 3 0.0011
234 TOXICITY TO VARIOUS AGENTS 180 0.0011
235 LETHARGY 61 0.0011
236 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 10 0.0010
237 INCREASED APPETITE 20 0.0010
238 POST-TRAUMATIC STRESS DISORDER 7 0.0010
239 MOOD SWINGS 33 0.0010
240 CONVERSION DISORDER 2 0.0010
241 GROWTH RETARDATION 3 0.0010
242 MYDRIASIS 13 0.0010
243 INABILITY TO AFFORD MEDICATION 10 0.0010
244 INFUSION SITE REACTION 3 0.0010
245 ALLERGIC REACTION TO EXCIPIENT 2 0.0010
246 MUSCLE RIGIDITY 12 0.0010
247 SALIVARY HYPERSECRETION 10 0.0010
248 POOR QUALITY DEVICE USED 10 0.0010
249 BLINDNESS UNILATERAL 14 0.0010
250 FOAMING AT MOUTH 2 0.0010
251 DYSPHORIA 5 0.0010
252 BREAST DISORDER 2 0.0010
253 PETIT MAL EPILEPSY 5 0.0010
254 IMPAIRED QUALITY OF LIFE 14 0.0010
255 TRISMUS 5 0.0010
256 SOCIAL PROBLEM 4 0.0010
257 BLOOD CREATININE DECREASED 3 0.0010
258 LIVEDO RETICULARIS 2 0.0010
259 RESPIRATORY RATE DECREASED 3 0.0010
260 AKATHISIA 13 0.0010
261 PRODUCT DISPENSING ISSUE 4 0.0009
262 TEARFULNESS 4 0.0009
263 INFUSION SITE BRUISING 2 0.0009
264 LANGUAGE DISORDER 2 0.0009
265 STAPHYLOCOCCAL BACTERAEMIA 4 0.0009
266 BIPOLAR DISORDER 10 0.0009
267 SOMNAMBULISM 6 0.0009
268 INFUSION SITE HAEMORRHAGE 3 0.0009
269 BIPOLAR I DISORDER 2 0.0009
270 NEAR DEATH EXPERIENCE 3 0.0009
271 DISTURBANCE IN ATTENTION 49 0.0009
272 SUICIDE ATTEMPT 55 0.0009
273 DRUG LEVEL INCREASED 15 0.0009
274 SOMNOLENCE 182 0.0009
275 COMA 43 0.0009
276 SUICIDAL IDEATION 82 0.0009
277 PRODUCT PHYSICAL ISSUE 18 0.0009
278 GASTROINTESTINAL HYPOMOTILITY 2 0.0009
279 BLOOD LOSS ANAEMIA 2 0.0009
280 GRANULOCYTOPENIA 5 0.0009
281 DRUG INTERACTION 139 0.0009
282 MIOSIS 7 0.0009
283 ORAL PRURITUS 2 0.0009
284 PANCREATITIS NECROTISING 2 0.0009
285 BLOOD URIC ACID INCREASED 5 0.0009
286 INFUSION SITE INFECTION 2 0.0009
287 DYSARTHRIA 32 0.0008
288 BLOOD PROLACTIN INCREASED 4 0.0008
289 PRODUCT CONTAMINATION 3 0.0008
290 GYNAECOMASTIA 26 0.0008
291 LIQUID PRODUCT PHYSICAL ISSUE 6 0.0008
292 HAEMORRHOIDAL HAEMORRHAGE 4 0.0008
293 HAEMATOLOGICAL INFECTION 2 0.0008
294 RENAL CELL CARCINOMA 4 0.0008
295 PARADOXICAL DRUG REACTION 3 0.0008
296 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 5 0.0008
297 HYPOTENSION 162 0.0008
298 DEVICE INFUSION ISSUE 2 0.0008
299 CATHETER SITE HAEMORRHAGE 2 0.0008
300 STATUS EPILEPTICUS 9 0.0008
301 SNORING 3 0.0008
302 CATHETER SITE INFECTION 3 0.0008
303 RESTLESSNESS 29 0.0008
304 CARDIOTOXICITY 7 0.0008
305 DEPRESSED LEVEL OF CONSCIOUSNESS 31 0.0008
306 DEVICE PHYSICAL PROPERTY ISSUE 6 0.0008
307 ABNORMAL UTERINE BLEEDING 2 0.0008
308 THERAPEUTIC PRODUCT EFFECT VARIABLE 3 0.0008
309 DEVICE INFORMATION OUTPUT ISSUE 6 0.0008
310 COMPLETED SUICIDE 64 0.0008
311 WITHDRAWAL SYNDROME 32 0.0008
312 BLOOD LACTIC ACID INCREASED 4 0.0008
313 POLYDIPSIA 3 0.0008
314 PRODUCT FORMULATION ISSUE 5 0.0008
315 APATHY 11 0.0008
316 PARANOIA 13 0.0008
317 OBESITY 12 0.0008
318 ARTERIOSPASM CORONARY 3 0.0007
319 ATRIOVENTRICULAR BLOCK COMPLETE 5 0.0007
320 OVERWEIGHT 4 0.0007
321 PRESYNCOPE 18 0.0007
322 MOOD ALTERED 20 0.0007
323 CLONUS 2 0.0007
324 SEIZURE 84 0.0007
325 HAIR GROWTH ABNORMAL 5 0.0007
326 STREPTOCOCCAL INFECTION 4 0.0007
327 FORMICATION 5 0.0007
328 PARKINSONISM 7 0.0007
329 TACHYCARDIA 63 0.0007
330 THERAPY PARTIAL RESPONDER 11 0.0007
331 OXYGEN SATURATION ABNORMAL 2 0.0007
332 COMA SCALE ABNORMAL 2 0.0007
333 PULMONARY FUNCTION TEST DECREASED 3 0.0007
334 DEVICE POWER SOURCE ISSUE 2 0.0007
335 NEGATIVE THOUGHTS 2 0.0007
336 PHYSICAL DISABILITY 3 0.0007
337 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 37 0.0007
338 PRODUCT TASTE ABNORMAL 9 0.0007
339 IMPAIRED GASTRIC EMPTYING 9 0.0007
340 PRODUCT AVAILABILITY ISSUE 15 0.0007
341 END STAGE RENAL DISEASE 12 0.0007
342 MASTICATION DISORDER 2 0.0007
343 SCOLIOSIS 4 0.0006
344 THINKING ABNORMAL 12 0.0006
345 APNOEA 5 0.0006
346 ASPIRATION 7 0.0006
347 BRAIN FOG 10 0.0006
348 BLEPHAROSPASM 4 0.0006
349 INFUSION SITE PRURITUS 2 0.0006
350 ELECTROENCEPHALOGRAM ABNORMAL 2 0.0006
351 BRAIN OEDEMA 8 0.0006
352 DRUG EFFECT INCREASED 2 0.0006
353 PULSE ABSENT 3 0.0006
354 HYPERSOMNIA 18 0.0006
355 EXPOSURE TO TOXIC AGENT 2 0.0006
356 TRANSPLANT REJECTION 5 0.0006
357 CUSHINGOID 2 0.0006
358 BLOOD TRIGLYCERIDES INCREASED 11 0.0006
359 PRESCRIBED OVERDOSE 12 0.0006
360 DIZZINESS POSTURAL 6 0.0006
361 DEVICE BREAKAGE 25 0.0006
362 HALLUCINATION, VISUAL 13 0.0006
363 HEPATITIS ACUTE 4 0.0006
364 EXPIRED DRUG ADMINISTERED 3 0.0006
365 OTITIS MEDIA 2 0.0006
366 PULMONARY OEDEMA 27 0.0006
367 ANXIETY DISORDER 2 0.0006
368 SEXUAL DYSFUNCTION 7 0.0006
369 INTENTIONAL DOSE OMISSION 17 0.0006
370 HYPOTHERMIA 6 0.0006
371 INSURANCE ISSUE 9 0.0006
372 ABNORMAL LOSS OF WEIGHT 4 0.0006
373 EUPHORIC MOOD 6 0.0006
374 ENDOCARDITIS 3 0.0006
375 INITIAL INSOMNIA 6 0.0006
376 BENIGN PROSTATIC HYPERPLASIA 3 0.0006
377 DELUSION 9 0.0006
378 HYPOPNOEA 2 0.0006
379 MALABSORPTION 3 0.0006
380 PRODUCT USE COMPLAINT 9 0.0006
381 MUSCLE CONTRACTIONS INVOLUNTARY 2 0.0006
382 BRONCHIOLITIS 2 0.0006
383 ABNORMAL WEIGHT GAIN 7 0.0006
384 LEARNING DISABILITY 3 0.0006
385 APPLICATION SITE IRRITATION 7 0.0006
386 HAEMORRHAGIC DIATHESIS 2 0.0006
387 FRUSTRATION 2 0.0006
388 GASTROENTERITIS VIRAL 10 0.0006
389 PRODUCT DISPENSING ERROR 12 0.0006
390 CRYING 20 0.0005
391 MAJOR DEPRESSION 4 0.0005
392 NONSPECIFIC REACTION 3 0.0005
393 HALLUCINATION 41 0.0005
394 DYSKINESIA 22 0.0005
395 DIABETIC KETOACIDOSIS 13 0.0005
396 ARTHROPOD BITE 4 0.0005
397 URINARY RETENTION 18 0.0005
398 DRUG DOSE OMISSION BY DEVICE 42 0.0005
399 MIDDLE INSOMNIA 10 0.0005
400 COGNITIVE DISORDER 25 0.0005
401 THERAPY NON-RESPONDER 24 0.0005
402 PRODUCT ADHESION ISSUE 19 0.0005
403 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 9 0.0005
404 ENCEPHALOPATHY 13 0.0005
405 AUTOIMMUNE THYROIDITIS 2 0.0005
406 FACE INJURY 2 0.0005
407 DERMATITIS CONTACT 6 0.0005
408 SLEEP DISORDER 37 0.0005
409 ANXIETY 148 0.0005
410 ACCIDENTAL OVERDOSE 19 0.0005
411 DELIRIUM 18 0.0005
412 HYPERVENTILATION 3 0.0005
413 ATRIOVENTRICULAR BLOCK 4 0.0005
414 RETCHING 11 0.0005
415 PULMONARY HAEMORRHAGE 4 0.0005
416 ENERGY INCREASED 3 0.0005
417 PSYCHOTIC DISORDER 15 0.0005
418 INSOMNIA 134 0.0005
419 SENSORY DISTURBANCE 8 0.0005
420 MENTAL IMPAIRMENT 12 0.0005
421 PRODUCT ADMINISTRATION ERROR 10 0.0005
422 LACTIC ACIDOSIS 16 0.0005
423 NIGHTMARE 17 0.0005
424 SLUGGISHNESS 5 0.0005
425 PARALYSIS 7 0.0005
426 GLOMERULAR FILTRATION RATE DECREASED 6 0.0005
427 CARDIOGENIC SHOCK 7 0.0005
428 TEMPERATURE INTOLERANCE 5 0.0005
429 DEVICE LEAKAGE 21 0.0005
430 MENSTRUAL DISORDER 4 0.0005
431 MENTAL DISORDER 21 0.0005
432 SWELLING OF EYELID 3 0.0005
433 HALLUCINATIONS, MIXED 2 0.0005
434 INFUSION SITE ERYTHEMA 4 0.0005
435 DRUG EFFECT LESS THAN EXPECTED 7 0.0005
436 AORTIC VALVE INCOMPETENCE 2 0.0005
437 DRUG PRESCRIBING ERROR 9 0.0005
438 MENTAL STATUS CHANGES 13 0.0005
439 POOR QUALITY SLEEP 10 0.0005
440 HYPERPROLACTINAEMIA 3 0.0005
441 WEIGHT INCREASED 103 0.0005
442 APPLICATION SITE ERYTHEMA 12 0.0005
443 TREATMENT NONCOMPLIANCE 25 0.0005
444 HEART RATE DECREASED 16 0.0005
445 DEPRESSED MOOD 24 0.0005
446 APPETITE DISORDER 3 0.0005
447 BLOOD CREATINE INCREASED 2 0.0005
448 EAR INFECTION 12 0.0005
449 VENTRICULAR FIBRILLATION 5 0.0004
450 MENINGITIS 3 0.0004
451 PRODUCT QUALITY ISSUE 61 0.0004
452 LEFT VENTRICULAR DYSFUNCTION 3 0.0004
453 THIRST 8 0.0004
454 LOSS OF LIBIDO 4 0.0004
455 ANAL INCONTINENCE 4 0.0004
456 LEUKOCYTOSIS 8 0.0004
457 DRUG EFFECT DELAYED 2 0.0004
458 APPLICATION SITE PRURITUS 10 0.0004
459 BLOOD PRESSURE SYSTOLIC DECREASED 2 0.0004
460 URINARY INCONTINENCE 13 0.0004
461 BLOOD TESTOSTERONE DECREASED 3 0.0004
462 EYE MOVEMENT DISORDER 3 0.0004
463 DYSPAREUNIA 2 0.0004
464 THERAPY CESSATION 22 0.0004
465 UNRESPONSIVE TO STIMULI 11 0.0004
466 CARDIAC ARREST 35 0.0004
467 MULTIPLE ORGAN DYSFUNCTION SYNDROME 12 0.0004
468 DIPLOPIA 11 0.0004
469 EATING DISORDER 9 0.0004
470 POISONING DELIBERATE 4 0.0004
471 PRODUCT SUPPLY ISSUE 3 0.0004
472 FEELING JITTERY 8 0.0004
473 NERVOUS SYSTEM DISORDER 13 0.0004
474 ALTERED STATE OF CONSCIOUSNESS 9 0.0004
475 RENAL TUBULAR NECROSIS 4 0.0004
476 DRY MOUTH 33 0.0004
477 SENSITIVE SKIN 3 0.0004
478 HYPERVOLAEMIA 2 0.0004
479 PALLOR 11 0.0004
480 MUCOUS STOOLS 2 0.0004
481 DEVICE USE ERROR 14 0.0004
482 FLUID INTAKE REDUCED 2 0.0004
483 NEUROTOXICITY 7 0.0004
484 BRAIN INJURY 4 0.0004
485 PRODUCT DOSE OMISSION 26 0.0004
486 OFF LABEL USE 347 0.0004
487 HYPERHIDROSIS 51 0.0004
488 TROPONIN INCREASED 3 0.0004
489 DISCOMFORT 24 0.0004
490 SHOCK 9 0.0004
491 DEPRESSION 89 0.0004
492 RIB FRACTURE 8 0.0004
493 FOOD ALLERGY 3 0.0004
494 LOW DENSITY LIPOPROTEIN INCREASED 3 0.0004
495 CONCUSSION 3 0.0004
496 HYPERTENSION 82 0.0004
497 POOR VENOUS ACCESS 4 0.0004
498 OVERDOSE 83 0.0004
499 INCONTINENCE 4 0.0004
500 BLOOD ALBUMIN DECREASED 3 0.0004
501 CONDITION AGGRAVATED 114 0.0004
502 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 18 0.0004
503 MOVEMENT DISORDER 12 0.0004
504 GASTROINTESTINAL MOTILITY DISORDER 2 0.0004
505 DECREASED ACTIVITY 4 0.0004
506 PHARYNGITIS STREPTOCOCCAL 4 0.0004
507 ERYTHEMA OF EYELID 2 0.0004
508 DRUG LEVEL BELOW THERAPEUTIC 2 0.0004
509 DECREASED APPETITE 84 0.0004
510 HYPERTENSIVE CRISIS 4 0.0004
511 HUNGER 5 0.0004
512 INTRACRANIAL PRESSURE INCREASED 2 0.0004
513 DRUG INEFFECTIVE 473 0.0004
514 WRONG TECHNIQUE IN DRUG USAGE PROCESS 13 0.0004
515 PRODUCT USE ISSUE 67 0.0004
516 CHRONIC KIDNEY DISEASE 27 0.0004
517 PRODUCT USE IN UNAPPROVED INDICATION 88 0.0004
518 CIRCULATORY COLLAPSE 6 0.0004
519 VITAMIN D DECREASED 3 0.0004
520 PRODUCT CONTAINER ISSUE 3 0.0003
521 NEUROLOGICAL SYMPTOM 2 0.0003
522 PSEUDOMONAS INFECTION 3 0.0003
523 EXERCISE TOLERANCE DECREASED 2 0.0003
524 MUSCLE TWITCHING 8 0.0003
525 HYSTERECTOMY 3 0.0003
526 METABOLIC DISORDER 2 0.0003
527 FEELING OF BODY TEMPERATURE CHANGE 2 0.0003
528 HYPOXIA 12 0.0003
529 PRODUCT COMMUNICATION ISSUE 3 0.0003
530 DECREASED INTEREST 2 0.0003
531 ATAXIA 4 0.0003
532 BLOOD PRESSURE INADEQUATELY CONTROLLED 2 0.0003
533 INJECTION SITE VESICLES 2 0.0003
534 RESTLESS LEGS SYNDROME 6 0.0003
535 EXOSTOSIS 3 0.0003
536 INCREASED TENDENCY TO BRUISE 3 0.0003
537 BLOOD THYROID STIMULATING HORMONE INCREASED 3 0.0003
538 DEVICE ADHESION ISSUE 5 0.0003
539 SPINAL OPERATION 4 0.0003
540 PRODUCT DISTRIBUTION ISSUE 3 0.0003
541 DERMATITIS ATOPIC 17 0.0003
542 EXTRAPYRAMIDAL DISORDER 8 0.0003
543 PRODUCT PRESCRIBING ISSUE 7 0.0003
544 INFUSION SITE EXTRAVASATION 2 0.0003
545 FLANK PAIN 3 0.0003
546 TARDIVE DYSKINESIA 9 0.0003
547 CONSTIPATION 69 0.0003
548 DRUG EFFECT DECREASED 17 0.0003
549 MIGRAINE 30 0.0003
550 HYPOPHAGIA 8 0.0003
551 THERAPEUTIC PRODUCT EFFECT DECREASED 14 0.0003
552 GALACTORRHOEA 2 0.0003
553 NEPHROLITHIASIS 14 0.0003
554 LOSS OF CONSCIOUSNESS 39 0.0003
555 DYSGRAPHIA 2 0.0003
556 RENAL INJURY 9 0.0003
557 HEART RATE INCREASED 30 0.0003
558 VENTRICULAR TACHYCARDIA 5 0.0003
559 CORONAVIRUS INFECTION 2 0.0003
560 THERAPEUTIC RESPONSE SHORTENED 10 0.0003
561 DEVICE ISSUE 27 0.0003
562 BLOOD PRESSURE DECREASED 20 0.0003
563 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 14 0.0003
564 PRODUCT DOSE OMISSION ISSUE 88 0.0003
565 BLOOD UREA INCREASED 5 0.0003
566 FEAR 8 0.0003
567 THERAPEUTIC RESPONSE DECREASED 18 0.0003
568 SCAR 5 0.0003
569 ABDOMINAL PAIN UPPER 60 0.0003
570 APPLICATION SITE RASH 4 0.0003
571 RESPIRATORY ARREST 8 0.0003
572 THERAPEUTIC RESPONSE UNEXPECTED 13 0.0003
573 TREMOR 48 0.0003
574 ENCEPHALITIS 2 0.0003
575 DEVICE DEFECTIVE 5 0.0003
576 COORDINATION ABNORMAL 4 0.0003
577 WEIGHT FLUCTUATION 3 0.0003
578 EXTRASYSTOLES 2 0.0003
579 CARPAL TUNNEL SYNDROME 4 0.0003
580 JOINT DISLOCATION 3 0.0003
581 DUODENAL ULCER 2 0.0003
582 ACUTE RESPIRATORY DISTRESS SYNDROME 5 0.0003
583 PRODUCT DOSE OMISSION IN ERROR 8 0.0003
584 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 20 0.0003
585 HEREDITARY ANGIOEDEMA 3 0.0003
586 BLOOD CREATINE PHOSPHOKINASE INCREASED 8 0.0003
587 GLYCOSYLATED HAEMOGLOBIN INCREASED 7 0.0003
588 INCORRECT PRODUCT ADMINISTRATION DURATION 6 0.0003
589 SKIN LACERATION 3 0.0003
590 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 5 0.0003
591 GASTROINTESTINAL PAIN 3 0.0003
592 FOOT DEFORMITY 3 0.0003
593 HYPOPHOSPHATAEMIA 2 0.0003
594 LOWER GASTROINTESTINAL HAEMORRHAGE 2 0.0003
595 VIRAL INFECTION 9 0.0003
596 DRUG WITHDRAWAL SYNDROME NEONATAL 4 0.0003
597 FEELING DRUNK 2 0.0003
598 DRUG INTOLERANCE 26 0.0003
599 INCORRECT DOSE ADMINISTERED BY DEVICE 7 0.0003
600 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 2 0.0003
601 ANHEDONIA 7 0.0003
602 EMOTIONAL DISTRESS 32 0.0003
603 GASTROINTESTINAL HAEMORRHAGE 22 0.0003
604 HAEMODYNAMIC INSTABILITY 2 0.0003
605 SLEEP APNOEA SYNDROME 5 0.0003
606 HYPERTHERMIA 2 0.0003
607 ACIDOSIS 2 0.0003
608 AMNESIA 17 0.0003
609 LOWER LIMB FRACTURE 5 0.0003
610 SYNCOPE 26 0.0003
611 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 52 0.0003
612 ADVERSE DRUG REACTION 23 0.0003
613 DEVICE DELIVERY SYSTEM ISSUE 7 0.0003
614 DIZZINESS 127 0.0003
615 CYANOSIS 4 0.0003
616 NO ADVERSE EVENT 46 0.0003
617 SICKLE CELL ANAEMIA WITH CRISIS 4 0.0003
618 DRUG SCREEN POSITIVE 2 0.0003
619 DISORIENTATION 10 0.0003
620 PNEUMOTHORAX 4 0.0003
621 PRESCRIBED UNDERDOSE 5 0.0003
622 BLOOD DISORDER 2 0.0002
623 BLOOD PRESSURE INCREASED 38 0.0002
624 NIGHT SWEATS 8 0.0002
625 SPEECH DISORDER 13 0.0002
626 PARAESTHESIA 39 0.0002
627 HYPERGLYCAEMIA 9 0.0002
628 PANIC ATTACK 9 0.0002
629 DECUBITUS ULCER 2 0.0002
630 GAIT INABILITY 8 0.0002
631 SURGERY 14 0.0002
632 PRODUCT COMPLAINT 6 0.0002
633 UNDERDOSE 17 0.0002
634 INFUSION SITE PAIN 3 0.0002
635 ARRHYTHMIA 11 0.0002
636 VOMITING 109 0.0002
637 PALPITATIONS 27 0.0002
638 ASTHMA 26 0.0002
639 CLOSTRIDIUM DIFFICILE INFECTION 5 0.0002
640 PULMONARY CONGESTION 3 0.0002
641 APPLICATION SITE PAIN 5 0.0002
642 COLD SWEAT 4 0.0002
643 FACIAL PAIN 2 0.0002
644 FOREIGN BODY IN REPRODUCTIVE TRACT 2 0.0002
645 ORAL PAIN 5 0.0002
646 ILLNESS 23 0.0002
647 GASTROINTESTINAL DISORDER 20 0.0002
648 GOUT 4 0.0002
649 PAIN OF SKIN 6 0.0002
650 HEAVY MENSTRUAL BLEEDING 2 0.0002
651 EXTRA DOSE ADMINISTERED 9 0.0002
652 SINUS CONGESTION 3 0.0002
653 DEVELOPMENTAL DELAY 2 0.0002
654 OROPHARYNGEAL DISCOMFORT 2 0.0002
655 HEAD INJURY 7 0.0002
656 DRUG EFFECT INCOMPLETE 8 0.0002
657 PERIPHERAL COLDNESS 3 0.0002
658 RHINORRHOEA 14 0.0002
659 FLUSHING 22 0.0002
660 HEADACHE 134 0.0002
661 FEELING ABNORMAL 51 0.0002
662 BLOOD SODIUM DECREASED 4 0.0002
663 FATIGUE 165 0.0002
664 RENAL FAILURE 28 0.0002
665 ECZEMA 11 0.0002
666 FUNGAL INFECTION 7 0.0002
667 PERIPHERAL SWELLING 32 0.0002
668 HYPERCHOLESTEROLAEMIA 2 0.0002
669 INFLUENZA 23 0.0002
670 NEURALGIA 5 0.0002
671 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 6 0.0002
672 NASAL CONGESTION 12 0.0002
673 COELIAC DISEASE 2 0.0002
674 HOSPICE CARE 2 0.0002
675 LIGAMENT SPRAIN 2 0.0002
676 EMBEDDED DEVICE 2 0.0002
677 HOSPITALISATION 31 0.0002
678 UPPER LIMB FRACTURE 4 0.0002
679 SWELLING FACE 13 0.0002
680 HYPERSENSITIVITY 37 0.0002
681 APHASIA 6 0.0002
682 UNEVALUABLE EVENT 15 0.0002
683 OSTEOPENIA 3 0.0002
684 DRY THROAT 2 0.0002
685 DRUG LEVEL DECREASED 2 0.0002
686 DRUG DISPENSING ERROR 3 0.0002
687 MOTOR DYSFUNCTION 2 0.0002
688 FEELING HOT 12 0.0002
689 ADVERSE EVENT 18 0.0002
690 DEHYDRATION 26 0.0002
691 NAUSEA 154 0.0002
692 INTENTIONAL PRODUCT USE ISSUE 17 0.0002
693 ANAPHYLACTIC SHOCK 5 0.0002
694 WEIGHT DECREASED 54 0.0002
695 ABDOMINAL DISCOMFORT 32 0.0002
696 INJECTION SITE DISCOMFORT 2 0.0002
697 MOUTH ULCERATION 4 0.0002
698 JOINT INJURY 4 0.0002
699 IMPAIRED WORK ABILITY 4 0.0002
700 BODY HEIGHT DECREASED 2 0.0002
701 CONFUSIONAL STATE 30 0.0002
702 MUSCLE TIGHTNESS 3 0.0002
703 BLOOD POTASSIUM INCREASED 3 0.0002
704 BACK DISORDER 3 0.0002
705 OEDEMA 10 0.0002
706 FALL 61 0.0002
707 INTENTIONAL PRODUCT MISUSE 16 0.0002
708 DRUG WITHDRAWAL SYNDROME 16 0.0002
709 VERTIGO 11 0.0002
710 PROCEDURAL PAIN 5 0.0002
711 TRANSAMINASES INCREASED 4 0.0002
712 MALNUTRITION 2 0.0002
713 RASH PAPULAR 4 0.0002
714 INCORRECT DRUG ADMINISTRATION DURATION 5 0.0002
715 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 32 0.0002
716 FLUID RETENTION 9 0.0002
717 FLATULENCE 10 0.0002
718 ABDOMINAL PAIN 41 0.0002
719 IMPAIRED DRIVING ABILITY 2 0.0002
720 SINUSITIS 18 0.0002
721 CARDIAC FAILURE 14 0.0002
722 RASH 76 0.0002
723 MUSCULOSKELETAL DISCOMFORT 3 0.0002
724 GASTROOESOPHAGEAL REFLUX DISEASE 14 0.0002
725 EYE IRRITATION 10 0.0002
726 NERVOUSNESS 9 0.0002
727 LIVER FUNCTION TEST ABNORMAL 5 0.0002
728 RENAL DISORDER 8 0.0002
729 AMENORRHOEA 3 0.0002
730 ACUTE KIDNEY INJURY 26 0.0002
731 HEAD DISCOMFORT 3 0.0002
732 BLOOD IRON DECREASED 2 0.0002
733 PRODUCT PRESCRIBING ERROR 4 0.0002
734 POLLAKIURIA 7 0.0002
735 MYOCLONUS 2 0.0002
736 VISION BLURRED 23 0.0002
737 BLOOD POTASSIUM DECREASED 5 0.0002
738 CONTUSION 16 0.0002
739 DEVICE DIFFICULT TO USE 11 0.0002
740 RASH PRURITIC 9 0.0002
741 LOCALISED INFECTION 4 0.0002
742 ADRENAL INSUFFICIENCY 2 0.0002
743 RESPIRATORY FAILURE 12 0.0002
744 OEDEMA PERIPHERAL 20 0.0002
745 NO THERAPEUTIC RESPONSE 2 0.0002
746 INJECTION SITE URTICARIA 4 0.0002
747 NASOPHARYNGITIS 30 0.0002
748 CARDIOMEGALY 2 0.0002
749 INJECTION SITE EXTRAVASATION 2 0.0002
750 LIMB DISCOMFORT 5 0.0002
751 GENERALISED OEDEMA 2 0.0002
752 EYE SWELLING 6 0.0002
753 ILEUS 2 0.0002
754 PNEUMONIA ASPIRATION 4 0.0002
755 CYSTITIS 5 0.0002
756 CHEST PAIN 29 0.0002
757 WHITE BLOOD CELL COUNT INCREASED 6 0.0002
758 POST PROCEDURAL COMPLICATION 3 0.0002
759 ACUTE RESPIRATORY FAILURE 3 0.0002
760 DRUG RESISTANCE 4 0.0002
761 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 11 0.0002
762 EAR PAIN 3 0.0002
763 INJECTION SITE INDURATION 2 0.0002
764 CHOKING 3 0.0002
765 SKIN FISSURES 3 0.0002
766 DEAFNESS 4 0.0002
767 MUSCLE SPASMS 28 0.0002
768 JOINT STIFFNESS 4 0.0002
769 EYE DISORDER 5 0.0002
770 GASTRITIS 4 0.0002
771 IMMUNE SYSTEM DISORDER 2 0.0002
772 DISABILITY 3 0.0002
773 ACTIVITIES OF DAILY LIVING IMPAIRED 3 0.0002
774 SINUS DISORDER 3 0.0002
775 COUGH 42 0.0001
776 URTICARIA 25 0.0001
777 INCORRECT DOSE ADMINISTERED 34 0.0001
778 FULL BLOOD COUNT DECREASED 3 0.0001
779 EYE PRURITUS 5 0.0001
780 DIARRHOEA 96 0.0001
781 BLOOD GLUCOSE INCREASED 28 0.0001
782 COVID-19 26 0.0001
783 FEEDING DISORDER 3 0.0001
784 RASH ERYTHEMATOUS 7 0.0001
785 PRODUCT PREPARATION ERROR 3 0.0001
786 INJECTION SITE REACTION 10 0.0001
787 ABNORMAL DREAMS 4 0.0001
788 ABDOMINAL DISTENSION 15 0.0001
789 FEELING COLD 4 0.0001
790 CARDIO-RESPIRATORY ARREST 6 0.0001
791 MASS 2 0.0001
792 DEVICE OCCLUSION 2 0.0001
793 THERAPY INTERRUPTED 10 0.0001
794 IRRITABLE BOWEL SYNDROME 3 0.0001
795 SWELLING 13 0.0001
796 PRURITUS GENERALISED 3 0.0001
797 PARAESTHESIA ORAL 2 0.0001
798 COMPLICATION ASSOCIATED WITH DEVICE 2 0.0001
799 NEEDLE ISSUE 4 0.0001
800 DYSSTASIA 4 0.0001
801 DYSPHAGIA 13 0.0001
802 DYSPHONIA 8 0.0001
803 CHILLS 16 0.0001
804 ACCIDENTAL EXPOSURE TO PRODUCT 14 0.0001
805 GAIT DISTURBANCE 26 0.0001
806 DYSURIA 5 0.0001
807 INJECTION SITE MASS 5 0.0001
808 URINARY TRACT INFECTION 23 0.0001
809 CATARACT 8 0.0001
810 COLON CANCER 2 0.0001
811 DRUG DOSE OMISSION 22 0.0001
812 ASTHENIA 50 0.0001
813 PNEUMONIA 43 0.0001
814 HEPATIC FAILURE 4 0.0001
815 DYSPEPSIA 13 0.0001
816 HEPATIC ENZYME INCREASED 9 0.0001
817 ECONOMIC PROBLEM 2 0.0001
818 ACNE 10 0.0001
819 TINNITUS 6 0.0001
820 SKIN DISCOLOURATION 6 0.0001
821 PRURITUS 50 0.0001
822 OROPHARYNGEAL PAIN 12 0.0001
823 MUSCULOSKELETAL CHEST PAIN 2 0.0001
824 ACUTE MYELOID LEUKAEMIA 2 0.0001
825 BALANCE DISORDER 11 0.0001
826 DISEASE RECURRENCE 6 0.0001
827 MEDICATION ERROR 7 0.0001
828 MOBILITY DECREASED 9 0.0001
829 METABOLIC ACIDOSIS 4 0.0001
830 BLOOD GLUCOSE DECREASED 6 0.0001
831 BLISTER 7 0.0001
832 MEMORY IMPAIRMENT 17 0.0001
833 FIBROMYALGIA 3 0.0001
834 MUSCULAR WEAKNESS 14 0.0001
835 BRONCHITIS 9 0.0001
836 ABASIA 3 0.0001
837 EXPIRED PRODUCT ADMINISTERED 4 0.0001
838 EPISTAXIS 9 0.0001
839 AGEUSIA 3 0.0001
840 LIP SWELLING 4 0.0001
841 RHABDOMYOLYSIS 5 0.0001
842 RENAL IMPAIRMENT 10 0.0001
843 SKIN EXFOLIATION 10 0.0001
844 HAEMATEMESIS 3 0.0001
845 ERECTILE DYSFUNCTION 3 0.0001
846 RECTAL HAEMORRHAGE 5 0.0001
847 EXPOSURE VIA SKIN CONTACT 3 0.0001
848 RESPIRATORY TRACT INFECTION 3 0.0001
849 PLEURAL EFFUSION 7 0.0001
850 RASH MACULAR 4 0.0001
851 DEVICE USE ISSUE 2 0.0001
852 MALAISE 50 0.0001
853 DEVICE MALFUNCTION 8 0.0001
854 DIABETES MELLITUS INADEQUATE CONTROL 2 0.0001
855 MENSTRUATION IRREGULAR 3 0.0001
856 PAIN IN EXTREMITY 33 0.0001
857 COMPLICATION OF DEVICE REMOVAL 2 0.0001
858 INFECTION 16 0.0001
859 LIMB INJURY 3 0.0001
860 PYREXIA 38 0.0001
861 BONE DISORDER 2 0.0001
862 RESPIRATORY DISTRESS 3 0.0001
863 UPPER RESPIRATORY TRACT INFECTION 5 0.0001
864 DEMENTIA 3 0.0001
865 BLOOD CHOLESTEROL INCREASED 5 0.0001
866 BACTERIAL INFECTION 2 0.0001
867 CARDIAC DISORDER 10 0.0001
868 INTESTINAL OBSTRUCTION 4 0.0001
869 PAIN IN JAW 3 0.0001
870 FOOT FRACTURE 2 0.0001
871 OCULAR HYPERAEMIA 5 0.0001
872 GASTRIC ULCER 2 0.0001
873 INJECTION SITE PRURITUS 7 0.0001
874 BACK PAIN 24 0.0001
875 HYPOGLYCAEMIA 5 0.0001
876 ERYTHEMA 21 0.0001
877 KIDNEY INFECTION 2 0.0001
878 ARTHRITIS 8 0.0001
879 HAEMATOCRIT DECREASED 2 0.0001
880 COMPLICATION OF DEVICE INSERTION 2 0.0001
881 DRY EYE 5 0.0001
882 ILL-DEFINED DISORDER 6 0.0001
883 BLINDNESS 4 0.0001
884 INJECTION SITE RASH 3 0.0001
885 DRUG ADMINISTRATION ERROR 3 0.0001
886 ALANINE AMINOTRANSFERASE INCREASED 6 0.0001
887 INFLAMMATION 5 0.0001
888 VISUAL IMPAIRMENT 12 0.0001
889 SWOLLEN TONGUE 3 0.0001
890 GENERAL PHYSICAL HEALTH DETERIORATION 11 0.0001
891 NEUROPATHY PERIPHERAL 9 0.0001
892 OSTEOARTHRITIS 4 0.0001
893 DYSGEUSIA 7 0.0001
894 ASPARTATE AMINOTRANSFERASE INCREASED 5 0.0001
895 HYPOTHYROIDISM 3 0.0001
896 FAECES DISCOLOURED 2 0.0001
897 SEPTIC SHOCK 4 0.0001
898 PSORIASIS 12 0.0001
899 IMPAIRED HEALING 3 0.0001
900 INJECTION SITE SWELLING 7 0.0001
901 INJECTION SITE PAIN 28 0.0001
902 STAPHYLOCOCCAL INFECTION 3 0.0001
903 DRY SKIN 12 0.0001
904 NECK PAIN 5 0.0001
905 GLOSSODYNIA 2 0.0001
906 TYPE 2 DIABETES MELLITUS 3 0.0001
907 ARTHRALGIA 37 0.0001
908 TRANSIENT ISCHAEMIC ATTACK 3 0.0001
909 EYE PAIN 5 0.0001
910 GASTRIC DISORDER 3 0.0001
911 SKIN IRRITATION 4 0.0001
912 HERPES ZOSTER 5 0.0001
913 INJURY 6 0.0001
914 SKIN BURNING SENSATION 6 0.0001
915 BLOOD PRESSURE FLUCTUATION 2 0.0001
916 STOMATITIS 5 0.0001
917 CEREBRAL INFARCTION 2 0.0001
918 LUNG DISORDER 4 0.0001
919 PAIN 50 0.0001
920 DYSPNOEA EXERTIONAL 3 0.0001
921 CELLULITIS 4 0.0001
922 ABDOMINAL PAIN LOWER 2 0.0001
923 CARDIOVASCULAR DISORDER 2 0.0001
924 HEPATITIS 2 0.0001
925 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 2 0.0001
926 JAUNDICE 2 0.0001
927 PSORIATIC ARTHROPATHY 3 0.0001
928 PULMONARY EMBOLISM 7 0.0001
929 HAEMATOCHEZIA 4 0.0001
930 DYSPNOEA 41 0.0001
931 ANAPHYLACTIC REACTION 4 0.0001
932 DRUG ABUSE 6 0.0001
933 BURNING SENSATION 5 0.0001
934 OXYGEN SATURATION DECREASED 4 0.0001
935 VAGINAL HAEMORRHAGE 3 0.0001
936 DEVICE DISLOCATION 3 0.0001
937 PRODUCT STORAGE ERROR 6 0.0001
938 ANAEMIA 13 0.0001
939 ASCITES 2 0.0001
940 ANGIOEDEMA 3 0.0001
941 WHEEZING 4 0.0001
942 HYPOAESTHESIA 10 0.0001
943 HOT FLUSH 5 0.0001
944 EXPOSURE DURING PREGNANCY 4 0.0001
945 PRODUCTIVE COUGH 3 0.0001
946 DEEP VEIN THROMBOSIS 4 0.0001
947 CHOLELITHIASIS 2 0.0001
948 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
949 DISEASE PROGRESSION 7 0.0001
950 CHEST DISCOMFORT 6 0.0001
951 HAEMATURIA 2 0.0001
952 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3 0.0001
953 MYOCARDIAL INFARCTION 10 0.0001
954 MUSCULOSKELETAL STIFFNESS 5 0.0001
955 PANCREATITIS 3 0.0001
956 LYMPHADENOPATHY 2 0.0001
957 INJECTION SITE ERYTHEMA 7 0.0001
958 ALOPECIA 11 0.0001
959 DRUG DEPENDENCE 9 0.0001
960 ARTHROPATHY 3 0.0001
961 HYPONATRAEMIA 3 0.0001
962 INJECTION SITE HAEMORRHAGE 4 0.0001
963 JOINT SWELLING 6 0.0000
964 OSTEOPOROSIS 2 0.0000
965 INFLUENZA LIKE ILLNESS 4 0.0000
966 HAEMORRHAGE 5 0.0000
967 CEREBROVASCULAR ACCIDENT 8 0.0000
968 MYALGIA 8 0.0000
969 PLATELET COUNT DECREASED 5 0.0000
970 HYPOACUSIS 2 0.0000
971 WHITE BLOOD CELL COUNT DECREASED 5 0.0000
972 SEPSIS 5 0.0000
973 COLITIS ULCERATIVE 2 0.0000
974 HYPOKALAEMIA 2 0.0000
975 DEATH 34 0.0000
976 HAEMOGLOBIN DECREASED 4 0.0000
977 MUSCULOSKELETAL PAIN 2 0.0000
978 INJECTION SITE BRUISING 3 0.0000
979 FOETAL EXPOSURE DURING PREGNANCY 3 0.0000
980 THROMBOCYTOPENIA 4 0.0000
981 CONVULSION 2 0.0000
982 MATERNAL EXPOSURE DURING PREGNANCY 3 0.0000
983 ATRIAL FIBRILLATION 3 0.0000
984 FEBRILE NEUTROPENIA 2 0.0000
985 NEOPLASM MALIGNANT 2 0.0000
986 NEUTROPENIA 4 0.0000
987 DIABETES MELLITUS 2 0.0000
988 CARDIAC FAILURE CONGESTIVE 2 0.0000
989 BREAST CANCER 2 0.0000